Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 25 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Post-antibiotic growth suppression of linezolid against Gram-positive bacteriaMunckhof, W.; Giles, C.; Turnidge, J.
2013Regional resistance surveillance program results for 12 Asia-Pacific nations (2011)Mendes, R.; Mendoza, M.; Banga Singh, K.; Castanheira, M.; Bell, J.; Turnidge, J.; Lin, S.; Jones, R.
2013Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution MethodEspinel-Ingroff, A.; Chowdhary, A.; Gonzalez, G.; Lass-Florl, C.; Martin-Mazuelos, E.; Meis, J.; Pelaez, T.; Pfaller, M.; Turnidge, J.
2016Predictability of phenotype in relation to common β-lactam resistance mechanisms in Escherichia coli and Klebsiella pneumoniaeAgyekum, A.; Fajardo-Lubián, A.; Ai, X.; Ginn, A.; Zong, Z.; Guo, X.; Turnidge, J.; Partridge, S.; Iredell, J.; Ledeboer, N.
2009Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agentsMendes, R.; Rhomberg, P.; Bell, J.; Turnidge, J.; Sader, H.
2002Prevalence of extended spectrum b-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99)Bell, J.; Turnidge, J.; Gales, A.; Pfaller, M.; Jones, R.
2011Cefazolin and enterobacteriaceae: Rationale for revised susceptibility testing breakpointsTurnidge, J.
2011Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high Vancomycin minimum inhibitory concentrationsHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Gao, W.; Christiansen, K.; Coombs, G.; Johnson, P.; Howden, B.
2001Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999Gales, A.; Jones, R.; Turnidge, J.; Rennie, R.; Ramphal, R.
2005Evaluation of colistin as an agent against multi-resistant Gram-negative bacteriaLi, J.; Nation, R.; Milne, R.; Turnidge, J.; Coulthard, K.